You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Harvard Business School
Medtronic
McKesson
AstraZeneca

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eribulin mesylate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

eribulin mesylate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc HALAVEN eribulin mesylate SOLUTION;INTRAVENOUS 201532 NDA BSP Pharmaceuticals SpA 43624-002-01 100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) > 3 mL in 1 TRAY
Eisai Inc HALAVEN eribulin mesylate SOLUTION;INTRAVENOUS 201532 NDA Eisai Inc. 62856-389-01 1 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Merck
Colorcon
Medtronic
AstraZeneca